A large international study led by a McMaster researcher has found a patient-centric treatment that works for people with mild asthma.

People with mild asthma are often prescribed a daily treatment regimen, but up to 80% do not follow the routine, using inhalers only when they have an asthma attack. Now the researchers have found an as-needed combined-drug inhaler is a viable treatment option.

Paul O'Byrne is the principal investigator on the study that suggests an inhaler with a combination of budesonide (a steroid that controls inflammation) and formoterol (a beta2-agonist that helps to open airways and make breathing easier) might be an alternative to conventional treatment strategies.

Read more about this story:

International Study Suggests Alternative Treatment for Mild Asthma (FHS News)